Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Sexually Transmitted Infections|March 30, 2021
Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019Heli Harvala, Claire Reynolds, Samreen Ijaz, et al.The Journal of Antimicrobial Chemotherapy|April 14, 2017
Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledgeEmilie R Elliot, Alieu Amara, Nicole Pagani, et al.Journal of Pharmaceutical and Biomedical Analysis|September 12, 2021
The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and salivaAlieu Amara, Sujan Dilly Penchala, Laura Else, et al.Wellcome Open Research|August 30, 2022
Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometryAdeniyi Olagunju, Jacinta Nwogu, Oluwasegun Eniayewu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2015
Breast milk pharmacokinetics of efavirenz and breastfed infants' exposure in genetically defined subgroups of mother-infant pairs: an observational studyAdeniyi Olagunju, Oluseye Bolaji, Alieu Amara, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 13, 2016
The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasmaSujan Dilly Penchala, Sandra Fawcett, Laura Else, et al.Journal of Neurovirology|March 16, 2018
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39)Arkaitz Imaz, Jordi Niubó, Alieu Amara, et al.Antimicrobial Agents and Chemotherapy|July 22, 2015
Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake CessationLaura Dickinson, H Manisha Yapa, Akil Jackson, et al.The Journal of Antimicrobial Chemotherapy|June 26, 2015
Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spotsAdeniyi Olagunju, Alieu Amara, Catriona Waitt, et al.BMC Medical Informatics and Decision Making|May 29, 2019
Improving health information systems during an emergency: lessons and recommendations from an Ebola treatment centre in Sierra LeoneShefali Oza, Kevin Wing, Alieu Amara Sesay, et al.Pageof 4